All News

Julia Vu, PharmD, joins to discuss industry-impacting NCPDP standards and how they are introducing new processes for medication delivery.

With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.

Pharmacist and diabetes expert Sandra Leal, PharmD, MPH, joins to discuss the importance of engaging pharmacists within primary care diabetes teams.

Pharmacies can build clinical workflows, bill like providers, and get paid for MTM and test-and-treat services patients value.

An open line of communication between care teams is key to improving patient outcomes.

Lisa Miller, PharmD, MSCP, discusses fragmentation in US menopause care and the role pharmacists can play in improving collaboration.

Controlling symptoms of allergy and asthma helps patients improve quality of life.

Declining Black-owned pharmacies reshape community care, and pharmacists can advance health equity today.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, provided his expert perspectives on the ongoing hantavirus outbreak.

Black pharmacists help to power civil rights, voter drives, and community care, linking history to today’s fight for health equity.

Black pharmacists help to fuel civil rights—through drugstores, voter drives, and health equity—offering lessons for today’s care gaps.

An exploration of key takeaways from the first 4 episodes of Scripted for Her, featuring host Natalie DiPietro Mager, PharmD, PhD, and experts from a variety of clinical backgrounds in women’s health.

Mapping data reveals where pharmacy access collapses and how policymakers can fight medication deserts.

Pharmacists expand into vaccines and telehealth, but state laws and reimbursement gaps persist.

Beyond medications, lifestyle modifications can also help patients curb allergy symptoms.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, and Staci-Marie Norman, PharmD, CDCES, FAPhA, discuss current trends regarding CGM use and access behind the pharmacy counter.

Medicare’s new GLP‑1 bridge program launches soon, easing access without shortages, and pharamcists are at the focal point of these transitions.

CMS pilots BALANCE and GLP-1 Bridge models to widen Medicare/Medicaid obesity drug coverage, spotlighting pharmacists’ role in access and safe therapy.

A PQA program shows how value-based pharmacy contracts, shared metrics, and better data boost immunizations and patient outcomes beyond dispensing.

Because pharmacists can review both prescription and refill histories, they are uniquely positioned to spot patterns of underuse or overuse of allergy and asthma medications.

Kevin Day, PharmD, provides insight into his role in the Pharmacist Quality Rewards Program and what it’s doing for patients in his community.

Drug pricing rules reshape pharmacy and manufacturer strategies, as transparency grows and 340B reforms intensify scrutiny.

Specialty pharmacy shifts toward holistic, empathetic care, easier oral therapies, and wider community access to advanced cell and gene treatments.

Pharmacy leaders face rapid change, which can boost agility and automate repetitive tasks.

Community pharmacists can help manage worsening wounds, coordinate rural care teams, and overcome time and scope limits to improve healing.

Pharmacies can use technology and artificial intelligence to cut specialty drug complexity, boost access and adherence, and help pharmacists guide patients.